{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:08:16Z","timestamp":1785146896269,"version":"3.55.0"},"reference-count":57,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2023.14089","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T12:12:25Z","timestamp":1696507945000},"source":"Crossref","is-referenced-by-count":5,"title":["Exploring the mechanism of resistance to vincristine in breast cancer cells using transcriptome sequencing technology"],"prefix":"10.3892","volume":"26","author":[{"given":"Yao","family":"Chen","sequence":"first","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"key20231122104126_b1-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20231122104126_b2-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: Highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"key20231122104126_b3-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies-improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann Oncol"},{"key":"key20231122104126_b4-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.7314\/APJCP.2015.16.15.6177","article-title":"Comparative efficacy of four imaging instruments for breast cancer screening","volume":"16","author":"Mehnati","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20231122104126_b5-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"e0128404","DOI":"10.1371\/journal.pone.0128404","article-title":"Identification of breast cancer using integrated information from MRI and mammography","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"key20231122104126_b6-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2174\/187152009788451833","article-title":"Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer","volume":"9","author":"Peng","year":"2009","journal-title":"Anticancer Agents Med Chem"},{"key":"key20231122104126_b7-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-0-387-73161-2_10","article-title":"Breast cancer prevention","volume":"141","author":"Reeder","year":"2008","journal-title":"Cancer Treat Res"},{"key":"key20231122104126_b8-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J Pathol"},{"key":"key20231122104126_b9-ol-26-6-14089","first-page":"349","article-title":"Cancer multidrug resistance: A review of recent drug discovery research","volume":"5","author":"Liscovitch","year":"2002","journal-title":"IDrugs"},{"key":"key20231122104126_b10-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/1097-0142(197504)35:4<1108::AID-CNCR2820350414>3.0.CO;2-Z","article-title":"Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer","volume":"35","author":"De Lena","year":"1975","journal-title":"Cancer"},{"key":"key20231122104126_b11-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/bcp.13126","article-title":"Microtubule destabilising agents: Far more than just antimitotic anticancer drugs","volume":"83","author":"Bates","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"key20231122104126_b12-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: A brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv Pharm Bull"},{"key":"key20231122104126_b13-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41467-021-23923-1","article-title":"IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation","volume":"12","author":"Hu","year":"2021","journal-title":"Nat Commun"},{"key":"key20231122104126_b14-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"e2213146119","DOI":"10.1073\/pnas.2213146119","article-title":"Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors","volume":"119","author":"Novototskaya-Vlasova","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20231122104126_b15-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1182\/blood.2022015853","article-title":"Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia","volume":"140","author":"Duncavage","year":"2022","journal-title":"Blood"},{"key":"key20231122104126_b16-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41580-022-00545-z","article-title":"The physiology of alternative splicing","volume":"24","author":"Marasco","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20231122104126_b17-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-021-00495-6","article-title":"SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer","volume":"6","author":"Lv","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"key20231122104126_b18-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/cells10040923","article-title":"Regulation of RNA splicing: Aberrant splicing regulation and therapeutic targets in cancer","volume":"10","author":"Kitamura","year":"2021","journal-title":"Cells"},{"key":"key20231122104126_b19-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"R467","DOI":"10.1530\/ERC-18-0068","article-title":"Splicing dysregulation as a driver of breast cancer","volume":"25","author":"Read","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"key20231122104126_b20-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"key20231122104126_b21-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20231122104126_b22-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.2147\/OTT.S250392","article-title":"Inhibition of VEGFA increases the sensitivity of ovarian cancer cells to chemotherapy by suppressing VEGFA-mediated autophagy","volume":"13","author":"Li","year":"2020","journal-title":"Onco Targets Ther"},{"key":"key20231122104126_b23-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.2147\/DDDT.S210220","article-title":"Aucubin protects chondrocytes against IL-1\u03b2-induced apoptosis in vitro and inhibits osteoarthritis in mice model","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"key20231122104126_b24-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20231122104126_b25-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20231122104126_b26-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"key20231122104126_b27-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1056\/NEJMra012284","article-title":"Breast and ovarian cancer","volume":"348","author":"Wooster","year":"2003","journal-title":"N Engl J Med"},{"key":"key20231122104126_b28-ol-26-6-14089","first-page":"5803","article-title":"Multiple microtubule alterations are associated with vinca alkaloid resistance in human leukemia cells","volume":"61","author":"Kavallaris","year":"2001","journal-title":"Cancer Res"},{"key":"key20231122104126_b29-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/bbrc.2000.2246","article-title":"Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms","volume":"269","author":"Sirotnak","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key20231122104126_b30-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"45082","DOI":"10.1074\/jbc.M303378200","article-title":"Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations","volume":"278","author":"Verrills","year":"2003","journal-title":"J Biol Chem"},{"key":"key20231122104126_b31-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: Role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20231122104126_b32-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0014-5793(93)80068-6","article-title":"Reduced influx is a factor in accounting for reduced vincristine accumulation in certain verapamil-hypersensitive multidrug-resistant CHO cell lines","volume":"320","author":"Stow","year":"1993","journal-title":"FEBS Lett"},{"key":"key20231122104126_b33-ol-26-6-14089","first-page":"387","article-title":"Detoxication of vinca alkaloids by human P450 CYP3A4-mediated metabolism: Implications for the development of drug resistance","volume":"294","author":"Yao","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"key20231122104126_b34-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2174\/18715206113139990091","article-title":"Apoptosis-related BCL2-family members: Key players in chemotherapy","volume":"14","author":"Kontos","year":"2014","journal-title":"Anticancer Agents Med Chem"},{"key":"key20231122104126_b35-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.biopha.2018.02.020","article-title":"Dual function of programmed cell death 10 (PDCD10) in drug resistance","volume":"101","author":"Urfali-Mamatoglu","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"key20231122104126_b36-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: Basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"key20231122104126_b37-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.placenta.2018.12.001","article-title":"The Angiotensin II type 1 receptor mediates the effects of low oxygen on early placental angiogenesis","volume":"75","author":"Delforce","year":"2019","journal-title":"Placenta"},{"key":"key20231122104126_b38-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/emboj\/20.11.2768","article-title":"A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells","volume":"20","author":"Takahashi","year":"2001","journal-title":"EMBO J"},{"key":"key20231122104126_b39-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0065-230X(09)02002-8","article-title":"PI3K\/PTEN signaling in angiogenesis and tumorigenesis","volume":"102","author":"Jiang","year":"2009","journal-title":"Adv Cancer Res"},{"key":"key20231122104126_b40-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/cvr\/cvm102","article-title":"Endothelial sprouting and angiogenesis: Matrix metalloproteinases in the lead","volume":"78","author":"van Hinsbergh","year":"2008","journal-title":"Cardiovasc Res"},{"key":"key20231122104126_b41-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: Back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"key20231122104126_b42-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.tips.2011.06.002","article-title":"Regulation of interleukin-1 in acute brain injury","volume":"32","author":"Brough","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"key20231122104126_b43-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/ni.2919","article-title":"The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response","volume":"15","author":"Baroja-Mazo","year":"2014","journal-title":"Nat Immunol"},{"key":"key20231122104126_b44-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1359-6101(97)00023-3","article-title":"Interleukin-1","volume":"8","author":"Dinarello","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20231122104126_b45-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"R421","DOI":"10.1530\/ERC-17-0309","article-title":"The role of IL-1B in breast cancer bone metastasis","volume":"25","author":"Tulotta","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"key20231122104126_b46-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"304","DOI":"10.15252\/emmm.201606840","article-title":"VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells","volume":"9","author":"Jang","year":"2017","journal-title":"EMBO Mol Med"},{"key":"key20231122104126_b47-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3892\/or.2014.3439","article-title":"MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K\/AKT and MAPK\/ERK pathways in ovarian cancer","volume":"32","author":"Wang","year":"2014","journal-title":"Oncol Rep"},{"key":"key20231122104126_b48-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"29527","DOI":"10.18632\/oncotarget.5012","article-title":"MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1","volume":"6","author":"Yan","year":"2015","journal-title":"Oncotarget"},{"key":"key20231122104126_b49-ol-26-6-14089","first-page":"2131","article-title":"Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma","volume":"9","author":"Zeng","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key20231122104126_b50-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1159\/000430237","article-title":"MicroRNA-140-5p inhibits the progression of colorectal cancer by targeting VEGFA","volume":"37","author":"Zhang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"key20231122104126_b51-ol-26-6-14089","first-page":"2898","article-title":"Vascular endothelial growth factor (VEGF) in breast cancer: Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen","volume":"60","author":"Adams","year":"2000","journal-title":"Cancer Res"},{"key":"key20231122104126_b52-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1757-2215-6-45","article-title":"The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors","volume":"6","author":"Lawicki","year":"2013","journal-title":"J Ovarian Res"},{"key":"key20231122104126_b53-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ygyno.2017.07.137","article-title":"Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer","volume":"147","author":"Fleming","year":"2017","journal-title":"Gynecol Oncol"},{"key":"key20231122104126_b54-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/ijc.29820","article-title":"Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer","volume":"138","author":"Fahmy","year":"2016","journal-title":"Int J Cancer"},{"key":"key20231122104126_b55-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/ijms19082155","article-title":"Interleukin-1 beta-A friend or foe in malignancies?","volume":"19","author":"Bent","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20231122104126_b56-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","article-title":"The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions","volume":"25","author":"Apte","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"key20231122104126_b57-ol-26-6-14089","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.169.1.469","article-title":"Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: In vivo analysis of tumor-stromal interaction","volume":"169","author":"Saijo","year":"2002","journal-title":"J Immunol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:42:14Z","timestamp":1700642534000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2023.14089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10,5]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2023.14089","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"article-number":"502"}}